Representative of the Nice University Hospital at the Eurobiomed Competitiveness Cluster since 2007.
After his Doctorate in Medicine, he spent a few years in Africa as head of a health structure (hospital, dispensary, major endemics team). Later he entered the French university curriculum, within the framework of Infectiology and Tropical Diseases at the University Hospital of Nice. Today he is a University Professor.
From the start of the HIV/AIDS epidemic, his team was firmly involved and published on the benefit of the pharmacological dosage of antiretrovirals in the placenta, which allowed the establishment of the first studies on the prevention of maternal-fetal transmission (Lancet 1989). The team then showed the importance of genotype for the choice of antiretroviral treatment (Lancet 1999). Pathophysiological knowledge of the consequences of HIV infection has been addressed through work on apoptosis (JID 2002). His team designed the first computerized medical record on HIV infection and hepatitis, now implemented in the majority of French hospitals.
At the same time, Pierre Dellamonica headed the Antibiology laboratory and was involved in the consequences of the misuse of antibiotics on bacterial resistance which is now a public health problem. It is in this capacity that he has contributed since 2000 to various plans to improve the use of antibiotics in human and veterinary medicine. He coordinates the European e.bug project which is an educational project aimed at children on hygiene, vaccination, the use of antibiotics and zoonoses. In 2006 he was a member of the board of directors of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and President of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Nice.
Pierre Delalamonica was responsible for the Medical coordination of the Human Immunodeficiency Information and Care Center at Nice University Hospital (CISIH) – from 1987 to 2007. At the same time, during the period 1988-2011 he was Head of Department of Infectious and tropical diseases at Nice University Hospital.
Président du COREVIH Paca-Est – de décembre 2007 à mai 2012 et membre de la Commission Médicale d’Etablissement du CHU de Nice (CME) – de 1996 à 1999 il & été élu Président Délégué à l’Offre de Soins 2003-2005.
Pierre Dellamonica was a referent for the management of health crises: AIDS, SARS, Avian flu, White powders, Multi-resistant tuberculosis, Emanations Archet 2, Swine flu • Departmental Technical Advisor in the biological field (NRBC) – from 2005 to 2008. Responsible for “University Clinic of Medical Specialties” Center at Nice University Hospital – from January 1, 2007 to December 31, 2010, at the same time he became an Infectiology consultant at the University Hospital and the University of Nice from September 2011 to December 2013. Part-time contract Infectiology (1 weekly shift) from April 1, 2014 to October 31, 2015.
Member of the working groups (arboviruses, vaccines, antibiotics, nosocomial infections) of the ARS PACA since 2011 and of the ANRS Scientific Council, Coordinated Action n°27 since January 2014.
